BETAMETHASONE DIPROPIONATE
Generic: BETAMETHASONE DIPROPIONATE
Sun Pharmaceutical IndustriesManufacturer
TOPICALRoute
BETAMETHASONE DIPROPIONATEActive Substance
2003-12-02Original Approval
BETAMETHASONE DIPROPIONATE is FDA application ANDA076508, sponsored by SUN PHARMA CANADA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2022-04-13
Betamethasone Dipropionate Cream USP, 0.05%, 45 grams tube, Rx only, MFG: Sandoz Pharma, NDC 0168-0055-46cGMP deviations: Temperature abuse
Class III2022-02-25
Clotrimazole and Betamethasone Dipropionate Cream USP, 1%/0.05%,15 g tubes, Rx only, Manufactured by: Taro PharmaceuticaFailed Content Uniformity Specifications: Out-of-specification result for the Betamethasone Dipropio
Top Reported Reactions
1
DRUG INEFFECTIVE
1,498 reports
2
OFF LABEL USE
672 reports
3
PSORIASIS
583 reports
4
NAUSEA
540 reports
5
MACULAR DEGENERATION
533 reports
6
PRURITUS
519 reports
7
PAIN
502 reports
8
FATIGUE
450 reports
9
HEADACHE
432 reports
10
CONDITION AGGRAVATED
428 reports